Skip to main content
Clinical Trials/NCT01545414
NCT01545414
Completed
Phase 3

Internet-based CBT for Depression and Anxiety in Parkinson's Disease: a Pilot Study and Randomized Controlled Trial

Karolinska Institutet1 site in 1 country150 target enrollmentFebruary 2012

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Parkinson's Disease
Sponsor
Karolinska Institutet
Enrollment
150
Locations
1
Primary Endpoint
Change (from baseline) in HADS
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

The purpose of this project is to develop and evaluate Internet-based Cognitive Behavioral Therapy (ICBT) for Parkinson's Disease (PD) patients with concurrent depression or anxiety symptoms. All treatment in this project is given as an adjunct to Standard Medical Treatment (SMT). ICBT will be compared to an Internet-based active control treatment (ICONTROL) and to SMT alone. It is hypothesized that both active treatments will be superior to SMT, and that ICBT will be superior to ICONTROL, in reducing symptoms of depression and anxiety.

Registry
clinicaltrials.gov
Start Date
February 2012
End Date
August 2013
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Viktor Kaldo

Principal Investigator

Karolinska Institutet

Eligibility Criteria

Inclusion Criteria

  • Clinical diagnosis of Parkinson's Disease
  • At least mild to moderate depression or anxiety defined as HADS-A or HADS-D \> 7

Exclusion Criteria

  • Has a high alcohol or drug use assessed by the AUDIT / DUDIT and assessment interview
  • Somatic or psychiatric problems that are directly contraindicated or seriously hamper the implementation of the treatment (eg, psychotic disorders or bipolar disorder)
  • Difficulties that hamper the use of a computer
  • The patient states difficulties in finding enough time for treatment
  • Too low cognitive functioning defined as MoCA \< 24
  • Too severe depression, defined as MADRS-S over 30
  • Too high suicidal risk defined as more than 4 points on the MADRS-S question 9 or according to the structured assessment interview

Outcomes

Primary Outcomes

Change (from baseline) in HADS

Time Frame: 12 weeks (Post), 3 and 6 months (FU)

Hospital Anxiety and Depression Scale - self rating, to measure anxiety and depression

Secondary Outcomes

  • Change (from baseline) in MADRS-S(12 weeks (Post), 3 and 6 months (FU))
  • Change (from baseline) in ISI(12 weeks (Post), 3 and 6 months (FU))
  • Change (from baseline) in PDQ-8(12 weeks (Post), 3 and 6 months (FU))
  • Change (from baseline) in NMSQuest(12 weeks (Post), 3 and 6 months (FU))
  • Change (from baseline) in EQ-5D(12 weeks (Post), 3 and 6 months (FU))
  • Change (from baseline) in SDS(12 weeks (Post), 3 and 6 months (FU))

Study Sites (1)

Loading locations...

Similar Trials